Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


New Amedeo service:

Amedeo COVID-19 (formerly 2019-nCoV)

Weekly publication summary


  Pulmonary Hypertension

  Free Subscription


24.02.2020

2 Am J Physiol Lung Cell Mol Physiol
3 Am J Respir Cell Mol Biol
1 Am J Respir Crit Care Med
1 Ann Hematol
1 Arterioscler Thromb Vasc Biol
1 Biomed Pharmacother
1 BMJ Case Rep
1 Br J Pharmacol
1 Chest
1 Circ Heart Fail
1 Curr Cardiol Rep
1 Curr Opin Anaesthesiol
1 Curr Opin Cardiol
1 DNA Cell Biol
1 Int Heart J
1 Int J Cardiol
1 Int J Rheum Dis
1 J Pediatr Surg
1 J Pharm Pract
2 J Thorac Cardiovasc Surg
1 J Vet Intern Med
1 Med Princ Pract
1 Med Sci Monit
1 N Engl J Med
1 Nutr Metab Cardiovasc Dis
2 PLoS One
1 Pol Arch Intern Med
2 Swiss Med Wkly


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Physiol Lung Cell Mol Physiol

  1. HOGAN SE, Rodriguez Salazar MP, Cheadle J, Glenn R, et al
    Mesenchymal stromal cell-derived exosomes improve mitochondrial health in pulmonary arterial hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2019;316:L723-L737.
    PubMed     Text format     Abstract available

  2. DIKALOVA A, Aschner JL, Kaplowitz MR, Cunningham G, et al
    Combined L-citrulline and tetrahydrobiopterin therapy improves NO signaling and ameliorates chronic hypoxia-induced pulmonary hypertension in newborn pigs.
    Am J Physiol Lung Cell Mol Physiol. 2020 Feb 19. doi: 10.1152/ajplung.00280.2019
    PubMed     Text format     Abstract available


    Am J Respir Cell Mol Biol

  3. STEARMAN RS, Bui QM, Speyer G, Handen A, et al
    Systems Analysis of the Human Pulmonary Arterial Hypertension Lung Transcriptome.
    Am J Respir Cell Mol Biol. 2019;60:637-649.
    PubMed     Text format     Abstract available

  4. VAN DER FEEN DE, Berger RMF, Bartelds B
    Converging Paths of Pulmonary Arterial Hypertension and Cellular Senescence.
    Am J Respir Cell Mol Biol. 2019;61:11-20.
    PubMed     Text format     Abstract available

  5. CALVIER L, Chouvarine P, Legchenko E, Kokeny G, et al
    Chronic TGF-beta1 Signaling in Pulmonary Arterial Hypertension Induces Sustained Canonical Smad3 Pathways in Vascular Smooth Muscle Cells.
    Am J Respir Cell Mol Biol. 2019;61:121-123.
    PubMed     Text format    


    Am J Respir Crit Care Med

  6. GRINNAN D, Farkas L
    A Novel Peptide for Immunomodulation in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2019;199:1460-1461.
    PubMed     Text format    


    Ann Hematol

  7. LOPEZ-MATTEI J, Verstovsek S, Fellman B, Iliescu C, et al
    Prevalence of pulmonary hypertension in myelofibrosis.
    Ann Hematol. 2020 Feb 19. pii: 10.1007/s00277-020-03962.
    PubMed     Text format     Abstract available


    Arterioscler Thromb Vasc Biol

  8. SATOH K, Kikuchi N, Kurosawa R, Shimokawa H, et al
    Checkpoint Kinase 1 Promotes the Development of Pulmonary Arterial Hypertension.
    Arterioscler Thromb Vasc Biol. 2019;39:1504-1506.
    PubMed     Text format    


    Biomed Pharmacother

  9. LI J, Jia M, Liu M, Cao Z, et al
    The effect of activated kappa-opioid receptor (kappa-OR) on the role of calcium sensing receptor (CaSR) in preventing hypoxic pulmonary hypertension development.
    Biomed Pharmacother. 2020;125:109931.
    PubMed     Text format     Abstract available


    BMJ Case Rep

  10. BENNITZ J, Simons M, Lorello GR
    Arteriovenous fistula and high output cardiac failure in a double lung transplant patient.
    BMJ Case Rep. 2019;12.
    PubMed     Text format     Abstract available


    Br J Pharmacol

  11. NIKAM VS, Nikam S, Sydykov A, Ahlbrecht K, et al
    Implication of in vivo circulating fibrocytes ablation in experimental pulmonary hypertension murine model.
    Br J Pharmacol. 2020 Feb 14. doi: 10.1111/bph.15025.
    PubMed     Text format     Abstract available


    Chest

  12. CHEMLA D, Boulate D, Weatherald J, Lau EMT, et al
    Golden Ratio and the Proportionality Between Pulmonary Pressure Components in Pulmonary Arterial Hypertension.
    Chest. 2019;155:991-998.
    PubMed     Text format     Abstract available


    Circ Heart Fail

  13. ZERN EK, Cheng S, Wolfson AM, Hamilton MA, et al
    Angiotensin Receptor-Neprilysin Inhibitor Therapy Reverses Pulmonary Hypertension in End-Stage Heart Failure Patients Awaiting Transplantation.
    Circ Heart Fail. 2020;13:e006696.
    PubMed     Text format    


    Curr Cardiol Rep

  14. FERRARA F, Zhou X, Gargani L, Wierzbowska-Drabik K, et al
    Echocardiography in Pulmonary Arterial Hypertension.
    Curr Cardiol Rep. 2019;21:22.
    PubMed     Text format     Abstract available


    Curr Opin Anaesthesiol

  15. GELZINIS T, Assaad S, Perrino AC Jr
    Right ventricular function during and after thoracic surgery.
    Curr Opin Anaesthesiol. 2020;33:27-36.
    PubMed     Text format     Abstract available


    Curr Opin Cardiol

  16. SISNIEGA C, Zayas N, Pulido T
    Advances in medical therapy for pulmonary arterial hypertension.
    Curr Opin Cardiol. 2019;34:98-103.
    PubMed     Text format     Abstract available


    DNA Cell Biol

  17. YANG N, Liu Y, Li T, Tuo Q, et al
    Role of Hydrogen Sulfide in Chronic Diseases.
    DNA Cell Biol. 2020;39:187-196.
    PubMed     Text format     Abstract available


    Int Heart J

  18. AKAGI S, Miki T, Sando Y, Fujii N, et al
    Chemotherapy Improved Pulmonary Arterial Hypertension in a Patient with Chronic-Active Epstein-Barr Virus Infection.
    Int Heart J. 2020;61:191-194.
    PubMed     Text format     Abstract available


    Int J Cardiol

  19. CHEN L, He W, Liu F, Wang T, et al
    Stroke in pulmonary hypertension: Is it predictable or preventable?
    Int J Cardiol. 2020;303:79.
    PubMed     Text format    


    Int J Rheum Dis

  20. ZHANG N, Zhao Y, Wang H, Sun W, et al
    Characteristics and risk factors for pulmonary arterial hypertension associated with primary Sjogren's syndrome: 15 new cases from a single center.
    Int J Rheum Dis. 2019;22:1775-1781.
    PubMed     Text format     Abstract available


    J Pediatr Surg

  21. LE DUC K, Mur S, Sharma D, Aubry E, et al
    Prostaglandin E1 in infants with congenital diaphragmatic hernia (CDH) and life-threatening pulmonary hypertension.
    J Pediatr Surg. 2020 Jan 28. pii: S0022-3468(20)30033.
    PubMed     Text format     Abstract available


    J Pharm Pract

  22. TORBIC H
    Management of Pulmonary Arterial Hypertension in the ICU.
    J Pharm Pract. 2019;32:303-313.
    PubMed     Text format     Abstract available


    J Thorac Cardiovasc Surg

  23. JAMIESON SW
    Commentary: Pulling the plug.
    J Thorac Cardiovasc Surg. 2019;158:617-618.
    PubMed     Text format    

  24. HUDDLESTON CB
    Commentary: What's the point?
    J Thorac Cardiovasc Surg. 2019;157:e411-e412.
    PubMed     Text format    


    J Vet Intern Med

  25. REINERO C, Visser LC, Kellihan HB, Masseau I, et al
    ACVIM consensus statement guidelines for the diagnosis, classification, treatment, and monitoring of pulmonary hypertension in dogs.
    J Vet Intern Med. 2020 Feb 17. doi: 10.1111/jvim.15725.
    PubMed     Text format     Abstract available


    Med Princ Pract

  26. YAYLALI YT, Yilmaz S, Akgun-Cagliyan G, Kilic O, et al
    Association of disease subtype and duration with echocardiographic evidence of pulmonary hypertension in myeloproliferative neoplasm.
    Med Princ Pract. 2020 Feb 19. pii: 000506596. doi: 10.1159/000506596.
    PubMed     Text format     Abstract available


    Med Sci Monit

  27. XING XQ, Li B, Xu SL, Liu J, et al
    MicroRNA-214-3p Regulates Hypoxia-Mediated Pulmonary Artery Smooth Muscle Cell Proliferation and Migration by Targeting ARHGEF12.
    Med Sci Monit. 2019;25:5738-5746.
    PubMed     Text format     Abstract available


    N Engl J Med

  28. D'SILVA K, Cockrill B, Anderson WJ, Miller AL, et al
    A Rapid Change in Pressure.
    N Engl J Med. 2020;382:563-570.
    PubMed     Text format    


    Nutr Metab Cardiovasc Dis

  29. YAN L, Wang Y, Zhang Z, Xu S, et al
    Postnatal delayed growth impacts cognition but rescues programmed impaired pulmonary vascular development in an IUGR rat model.
    Nutr Metab Cardiovasc Dis. 2019;29:1418-1428.
    PubMed     Text format     Abstract available


    PLoS One

  30. ZOUK AN, Gulati S, Xing D, Wille KM, et al
    Pulmonary artery enlargement is associated with pulmonary hypertension and decreased survival in severe cystic fibrosis: A cohort study.
    PLoS One. 2020;15:e0229173.
    PubMed     Text format     Abstract available

  31. TSUTSUMI T, Nagaoka T, Yoshida T, Wang L, et al
    Nintedanib ameliorates experimental pulmonary arterial hypertension via inhibition of endothelial mesenchymal transition and smooth muscle cell proliferation.
    PLoS One. 2019;14:e0214697.
    PubMed     Text format     Abstract available


    Pol Arch Intern Med

  32. KOPEC G, Waligora M, Jonas K, Stepniewski J, et al
    Epoprostenol therapy for pulmonary arterial hypertension: the first Polish experience.
    Pol Arch Intern Med. 2019;129:65-68.
    PubMed     Text format    


    Swiss Med Wkly

  33. CARRATU P, Dragonieri S, Resta O
    Comment on: Hostettler K, et al. Bosentan for patients with steroid-resistant pulmonary sarcoidosis: a randomised controlled trial.
    Swiss Med Wkly. 2019;149:w20132.
    PubMed     Text format    

  34. HOSTETTLER KE, Brutsche MH
    Reply to comment by Carratu P, et al. on: Hostettler K, et al. Bosentan for patients with steroid-resistant pulmonary sarcoidosis: a randomised controlled trial.
    Swiss Med Wkly. 2019;149:w20133.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: